Excellent Safety Profile

ERr 731 has been professionally recommended for over 20 years with no serious adverse events reported and no clinically relevant changes in safety parameters have been observed in clinical trials.

Multiple short- and long-term studies with over 400 peri- and postmenopausal women—published in peer-reviewed journals—confirm efficacy and predicted safety*